{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:01:32Z","timestamp":1769270492601,"version":"3.49.0"},"reference-count":220,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["CB10392"],"award-info":[{"award-number":["CB10392"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Plague, caused by the bacterial pathogen Yersinia pestis, is a vector-borne disease that has caused millions of human deaths over several centuries. Presently, human plague infections continue throughout the world. Transmission from one host to another relies mainly on infected flea bites, which can cause enlarged lymph nodes called buboes, followed by septicemic dissemination of the pathogen. Additionally, droplet inhalation after close contact with infected mammals can result in primary pneumonic plague. Here, we review research advances in the areas of vaccines and therapeutics for plague in context of Y. pestis virulence factors and disease pathogenesis. Plague continues to be both a public health threat and a biodefense concern and we highlight research that is important for infection mitigation and disease treatment.<\/jats:p>","DOI":"10.3390\/biomedicines9101421","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T21:19:32Z","timestamp":1633900772000},"page":"1421","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Plague Prevention and Therapy: Perspectives on Current and Future Strategies"],"prefix":"10.3390","volume":"9","author":[{"given":"Raysa","family":"Rosario-Acevedo","sequence":"first","affiliation":[{"name":"Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, MD 21702, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergei S.","family":"Biryukov","sequence":"additional","affiliation":[{"name":"Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, MD 21702, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6959-8176","authenticated-orcid":false,"given":"Joel A.","family":"Bozue","sequence":"additional","affiliation":[{"name":"Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, MD 21702, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher K.","family":"Cote","sequence":"additional","affiliation":[{"name":"Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, MD 21702, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.tim.2015.11.008","article-title":"Pneumonic plague: The darker side of Yersinia pestis","volume":"24","author":"Pechous","year":"2016","journal-title":"Trends Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41435-019-0065-0","article-title":"Yersinia pestis and plague: An updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics","volume":"20","author":"Demeure","year":"2019","journal-title":"Genes Immun."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Stenseth, N.C., Atshabar, B.B., Begon, M., Belmain, S.R., Bertherat, E., Carniel, E., Gage, K.L., Leirs, H., and Rahalison, L. (2008). Plague: Past, present, and future. PLoS Med., 5.","DOI":"10.1371\/journal.pmed.0050003"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"14043","DOI":"10.1073\/pnas.96.24.14043","article-title":"Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis","volume":"96","author":"Achtman","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.amjmed.2020.08.019","article-title":"History of the plague: An ancient pandemic for the age of COVID-19","volume":"134","author":"Glatter","year":"2021","journal-title":"Am. J. Med."},{"key":"ref_6","first-page":"1845","article-title":"Yersinia pestis","volume":"3","author":"Brubaker","year":"2015","journal-title":"Mol. Med. Microbiol."},{"key":"ref_7","first-page":"11","article-title":"The history of plague\u2014Part 1. The three great pandemics","volume":"20","author":"Frith","year":"2012","journal-title":"J. Mil. Vet. Health"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e00044-19","DOI":"10.1128\/CMR.00044-19","article-title":"Yersinia pestis: The natural history of plague","volume":"34","author":"Barbieri","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.cmi.2016.08.031","article-title":"Molecular history of plague","volume":"22","author":"Drancourt","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_10","first-page":"20182429","article-title":"The third plague pandemic in Europe","volume":"286","author":"Bramanti","year":"2019","journal-title":"Proc. Biol. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1051\/vetres:2008039","article-title":"Adaptive strategies of Yersinia pestis to persist during inter-epizootic and epizootic periods","volume":"40","author":"Eisen","year":"2009","journal-title":"Vet. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jinf.2012.09.010","article-title":"Plague: History and contemporary analysis","volume":"66","author":"Raoult","year":"2013","journal-title":"J. Infect."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1111\/zph.12419","article-title":"Human case of bubonic plague resulting from the bite of a wild Gunnison\u2019s prairie dog during translocation from a plague-endemic area","volume":"65","author":"Melman","year":"2018","journal-title":"Zoonoses Public Health"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Dai, R., Wei, B., Xiong, H., Yang, X., Peng, Y., He, J., Jin, J., Wang, Y., Zha, X., and Zhang, Z. (2018). Human plague associated with Tibetan sheep originates in marmots. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006635"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10393-016-1133-9","article-title":"Evaluation of Yersinia pestis transmission pathways for sylvatic plague in prairie dog populations in the Western U.S","volume":"13","author":"Richgels","year":"2016","journal-title":"Ecohealth"},{"key":"ref_16","unstructured":"CDC (2011). Fatal laboratory-acquired infection with an attenuated Yersinia pestis Strain\u2014Chicago, Illinois, 2009. MMWR Morb. Mortal. Wkly. Rep., 60, 201\u2013205."},{"key":"ref_17","unstructured":"Bozue, J.A., Cote, C.K., and Glass, P.J. (2018). Plague. Textbook of Military Medicine: Medical Aspects of Biological Warfare, Borden Institute US Army Medical Department Center and School Health Readiness Center of Excellence."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e01519-17","DOI":"10.1128\/JCM.01519-17","article-title":"Plague: Recognition, treatment, and prevention","volume":"56","author":"Yang","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/978-94-024-0890-4_11","article-title":"Plague: Clinics, diagnosis and treatment","volume":"918","author":"Nikiforov","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_20","unstructured":"Dennis, D.T., Gage, K.L., Gratz, N.G., Poland, J.D., and Tikhomirov, E. (1999). Plague Manual: Epidemiology, Distribution, Surveillance and Control, World Health Organization. No. WHO\/CDS\/CSR\/EDC\/99.2."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Sebbane, F., and Lemaitre, N. (2021). Antibiotic therapy of plague: A review. Biomolecules, 11.","DOI":"10.3390\/biom11050724"},{"key":"ref_22","first-page":"E5","article-title":"Bichat guidelines for the clinical management of plague and bioterrorism-related plague","volume":"9","author":"Bossi","year":"2004","journal-title":"Euro Surveill"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Lema\u00eetre, N., Ricard, I., Pradel, E., Folign\u00e9, B., Courcol, R., Simonet, M., and Sebbane, F. (2012). Efficacy of ciprofloxacin-gentamicin combination therapy in murine bubonic plague. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0052503"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1086\/381545","article-title":"Gentamicin and tetracyclines for the treatment of human plague: Review of 75 cases in New Mexico, 1985\u20131999","volume":"38","author":"Boulanger","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fmicb.2010.00119","article-title":"Model systems to study plague pathogenesis and develop new therapeutics","volume":"1","author":"Lawrenz","year":"2010","journal-title":"Front. Microbiol."},{"key":"ref_26","unstructured":"Dillard, R.L., and Juergens, A.L. (2020). Plague, StatPearls."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Marrie, T.J. (2001). Pneumonia Caused by Yersinia pestis: Plague Pneumonia, in Community-Acquired Pneumonia, Springer.","DOI":"10.1007\/b111487"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1086\/428617","article-title":"Risk of person-to-person transmission of pneumonic plague","volume":"40","author":"Kool","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/B978-0-443-06668-9.50047-8","article-title":"Plague","volume":"1","author":"Dennis","year":"2006","journal-title":"Trop. Infect. Dis."},{"key":"ref_30","unstructured":"Cohen, J., Powderly, W.G., and Opal, S.M. (2017). 126\u2014Plague. Infectious Diseases, Elsevier. [4th ed.]."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1128\/CMR.00033-15","article-title":"Bioterrorism and the role of the clinical microbiology laboratory","volume":"29","author":"Wagar","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jobb.2020.02.001","article-title":"Deliberate release: Plague\u2014A review","volume":"2","author":"Ansari","year":"2020","journal-title":"J. Biosaf. Biosecur."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-94-024-0890-4_7","article-title":"Pathology and pathogenesis of Yersinia pestis","volume":"918","author":"Du","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1093\/cid\/ciz1233","article-title":"The African green monkey model of pneumonic plague and US Food and Drug Administration approval of antimicrobials under the animal rule","volume":"70","author":"Hewitt","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.micpath.2010.10.002","article-title":"Cynomolgus macaque model for pneumonic plague","volume":"50","author":"Warren","year":"2011","journal-title":"Microb. Pathog."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/IAI.00403-06","article-title":"Delayed inflammatory response to primary pneumonic plague occurs in both outbred and inbred mice","volume":"75","author":"Bubeck","year":"2007","journal-title":"Infect. Immun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"17786","DOI":"10.1073\/pnas.0506840102","article-title":"Progression of primary pneumonic plague: A mouse model of infection, pathology, and bacterial transcriptional activity","volume":"102","author":"Lathem","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Pechous, R.D., Sivaraman, V., Price, P.A., Stasulli, N.M., and Goldman, W.E. (2013). Early host cell targets of Yersinia pestis during primary pneumonic plague. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003679"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/infdis\/jiaa094","article-title":"A dual role for the plasminogen activator protease during the preinflammatory phase of primary pneumonic plague","volume":"222","author":"Banerjee","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e02302-14","DOI":"10.1128\/mBio.02302-14","article-title":"In vivo transcriptional profiling of Yersinia pestis reveals a novel bacterial mediator of pulmonary inflammation","volume":"6","author":"Pechous","year":"2015","journal-title":"mBio"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1128\/IAI.01477-08","article-title":"Molecular Darwinian evolution of virulence in Yersina pestis","volume":"77","author":"Zhou","year":"2020","journal-title":"Infect. Immun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1046\/j.1365-2958.2000.01993.x","article-title":"Characterization of the O-antigen gene clusters of Yersinia pseudotuberculosis and the cryptic O-antigen gene cluster of Yersinia pestis shows that the plague bacillus is most closely related to and has evolved from Y. pseudotuberculosis serotype O:1b","volume":"37","author":"Skurnik","year":"2000","journal-title":"Mol. Microbiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"11824","DOI":"10.1074\/jbc.274.17.11824","article-title":"Expression, characterization, and mutagenesis of the Yersinia pestis murine toxin, a phospholipase D superfamily member","volume":"274","author":"Rudolph","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_44","first-page":"51","article-title":"Studies on immunization against plague. XV. The pathophysiologic action of the toxin of Pasteurella pestis in experimental animals","volume":"19","author":"Schar","year":"1956","journal-title":"Schweiz Z Pathol. Bakteriol."},{"key":"ref_45","unstructured":"Bergdoll, M.S., Enterotoxins, T.C., and Montie, S.J.A. (1970). Microbial Toxins, Academic Press."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1126\/science.1069972","article-title":"Role of Yersinia murine toxin in survival of Yersinia pestis in the midgut of the flea vector","volume":"296","author":"Hinnebusch","year":"2002","journal-title":"Science"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1128\/jb.72.6.851-857.1956","article-title":"Electron microscopic study of the extracellular materials of Pasteurella pestis","volume":"72","author":"Chen","year":"1956","journal-title":"J. Bacteriol."},{"key":"ref_48","first-page":"156","article-title":"Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops)","volume":"120","author":"Davis","year":"1996","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1128\/jb.67.4.438-449.1954","article-title":"Studies on immunization against plague. VI. Growth of Pasteurella pestis and the production of the envelope and other soluble antigens in a casein hydrolyzate mineral glucose medium","volume":"67","author":"Engelsberg","year":"1954","journal-title":"J. Bacteriol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1128\/JB.01840-07","article-title":"Biogenesis of the fraction 1 capsule and analysis of the ultrastructure of Yersinia pestis","volume":"190","author":"Runco","year":"2008","journal-title":"J. Bacteriol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1128\/IAI.70.3.1453-1460.2002","article-title":"Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis","volume":"70","author":"Du","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_52","first-page":"299","article-title":"Studies on the contribution of the F1 capsule-associated plasmid pFra to the virulence of Yersinia pestis","volume":"13","author":"Welkos","year":"1995","journal-title":"Contrib. Microbiol. Immunol."},{"key":"ref_53","first-page":"408","article-title":"An unusual strain of Pasteurella pestis isolated from a fatal human case of plague","volume":"23","author":"Winter","year":"1960","journal-title":"Bull. World Health Organ."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Sebbane, F., Uversky, V.N., and Anisimov, A.P. (2020). Yersinia pestis plasminogen activator. Biomolecules, 10.","DOI":"10.3390\/biom10111554"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-1-4614-3561-7_32","article-title":"Substrates of the plasminogen activator protease of Yersinia pestis","volume":"954","author":"Caulfield","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1538-7836.2007.02519.x","article-title":"Fibrin and fibrinolysis in infection and host defense","volume":"5","author":"Degen","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.1439793","article-title":"A surface protease and the invasive character of plague","volume":"258","author":"Sodeinde","year":"1992","journal-title":"Science"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.chom.2014.03.005","article-title":"The Pla protease of Yersinia pestis degrades fas ligand to manipulate host cell death and inflammation","volume":"15","author":"Caulfield","year":"2014","journal-title":"Cell Host Microbe"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1126\/science.1137195","article-title":"A plasminogen-activating protease specifically controls the development of primary pneumonic plague","volume":"315","author":"Lathem","year":"2007","journal-title":"Science"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1099\/00221287-138-8-1679","article-title":"Adhesive properties conferred by the plasminogen activator of Yersinia pestis","volume":"138","author":"Kienle","year":"1992","journal-title":"J. Gen. Microbiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.1128\/IAI.66.12.5755-5762.1998","article-title":"Expression of plasminogen activator Pla of Yersinia pestis enhances bacterial attachment to the mammalian extracellular matrix","volume":"66","author":"Virkola","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1574-6968.2006.00382.x","article-title":"Adhesive properties of the purified plasminogen activator Pla of Yersinia pestis","volume":"262","author":"Lobo","year":"2006","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1128\/IAI.68.8.4523-4530.2000","article-title":"Invasion of epithelial cells by Yersinia pestis: Evidence for a Y. pestis-specific invasin","volume":"68","author":"Cowan","year":"2000","journal-title":"Infect. Immun."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0014-5793(01)02775-2","article-title":"The Pla surface protease\/adhesin of Yersinia pestis mediates bacterial invasion into human endothelial cells","volume":"504","author":"Kukkonen","year":"2001","journal-title":"FEBS Lett."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1128\/IAI.67.9.4801-4813.1999","article-title":"LcrV of Yersinia pestis enters infected eukaryotic cells by a virulence plasmid-independent mechanism","volume":"67","author":"Fields","year":"1999","journal-title":"Infect. Immun."},{"key":"ref_66","first-page":"301","article-title":"The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague","volume":"12","author":"Derewenda","year":"2004","journal-title":"Structure"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1128\/jb.173.8.2649-2657.1991","article-title":"The Yersinia pestis V antigen is a regulatory protein necessary for Ca2(+)-dependent growth and maximal expression of low-Ca2+ response virulence genes","volume":"173","author":"Price","year":"1991","journal-title":"J. Bacteriol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1128\/JB.00539-07","article-title":"Structure-function analysis of the C-terminal domain of LcrV from Yersinia pestis","volume":"189","author":"Hamad","year":"2007","journal-title":"J. Bacteriol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"DiMezzo, T.L., Ruthel, G., Brueggemann, E.E., Hines, H.B., Ribot, W.J., Chapman, C.E., Powell, B.S., and Welkos, S.L. (2009). In vitro intracellular trafficking of virulence antigen during infection by Yersinia pestis. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006281"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.4049\/jimmunol.168.3.1315","article-title":"Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice","volume":"168","author":"Sing","year":"2002","journal-title":"J. Immunol."},{"key":"ref_71","first-page":"173","article-title":"Regulation of expression of V antigen and outer membrane proteins in Yersinia pestis","volume":"9","author":"Perry","year":"1987","journal-title":"Contrib. Microbiol. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1128\/iai.54.2.428-434.1986","article-title":"A low-Ca2+ response operon encodes the V antigen of Yersinia pestis","volume":"54","author":"Perry","year":"1986","journal-title":"Infect. Immun."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1128\/jb.179.4.1307-1316.1997","article-title":"Yersinia pestis LcrV forms a stable complex with LcrG and may have a secretion-related regulatory role in the low-Ca2+ response","volume":"179","author":"Nilles","year":"1997","journal-title":"J. Bacteriol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1128\/IAI.67.10.5395-5408.1999","article-title":"Virulence role of V antigen of Yersinia pestis at the bacterial surface","volume":"67","author":"Fields","year":"1999","journal-title":"Infect. Immun."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1128\/IAI.73.3.1532-1542.2005","article-title":"Antibody against V antigen prevents Yop-dependent growth of Yersinia pestis","volume":"73","author":"Philipovskiy","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1128\/JB.180.13.3410-3420.1998","article-title":"The V antigen of Yersinia pestis regulates Yop vectorial targeting as well as Yop secretion through effects on YopB and LcrG","volume":"180","author":"Nilles","year":"1998","journal-title":"J. Bacteriol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2958.1990.tb00635.x","article-title":"The cytotoxic protein YopE of Yersinia obstructs the primary host defence","volume":"4","author":"Rosqvist","year":"1990","journal-title":"Mol. Microbiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1128\/iai.63.2.681-685.1995","article-title":"Inhibition of the Fc receptor-mediated oxidative burst in macrophages by the Yersinia pseudotuberculosis tyrosine phosphatase","volume":"63","author":"Bliska","year":"1995","journal-title":"Infect. Immun."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1128\/iai.63.8.3117-3124.1995","article-title":"Yersinia pseudotuberculosis inhibits Fc receptor-mediated phagocytosis in J774 cells","volume":"63","author":"Andersson","year":"1995","journal-title":"Infect. Immun."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1128\/IAI.70.8.4165-4176.2002","article-title":"Role of Yops and adhesins in resistance of Yersinia enterocolitica to phagocytosis","volume":"70","author":"Grosdent","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1128\/iai.63.7.2570-2575.1995","article-title":"Role of Yops in inhibition of phagocytosis and killing of opsonized Yersinia enterocolitica by human granulocytes","volume":"63","author":"Visser","year":"1995","journal-title":"Infect. Immun."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1046\/j.1365-2958.1999.01254.x","article-title":"Yersinia enterocolitica type III secretion: An mRNA signal that couples translation and secretion of YopQ","volume":"31","author":"Anderson","year":"1999","journal-title":"Mol. Microbiol."},{"key":"ref_83","first-page":"1","article-title":"Using evidence to inform response to the 2017 plague outbreak in Madagascar: A view from the WHO African Regional Office","volume":"147","author":"Heitzinger","year":"2018","journal-title":"Epidemiol. Infect."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.epidem.2018.05.001","article-title":"The 2017 plague outbreak in Madagascar: Data descriptions and epidemic modelling","volume":"25","author":"Nguyen","year":"2018","journal-title":"Epidemics"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Vall\u00e8s, X., Stenseth, N.C., Demeure, C., Horby, P., Mead, P.S., Cabanillas, O., Ratsitorahina, M., Rajerison, M., Andrianaivoarimanana, V., and Ramasindrazana, B. (2020). Human plague: An old scourge that needs new answers. PLoS Negl. Trop. Dis., 14.","DOI":"10.1371\/journal.pntd.0008251"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1017\/S0025727300072124","article-title":"Plague today","volume":"52","author":"Carniel","year":"2008","journal-title":"Med. Hist. Suppl."},{"key":"ref_87","first-page":"89","article-title":"Plague around the world, 2010\u20132015","volume":"91","author":"Bertherat","year":"2016","journal-title":"Wkly. Epidemiol. Rec."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1749-4877.2011.00277.x","article-title":"Yersinia pestis: Examining wildlife plague surveillance in China and the USA","volume":"7","author":"Bevins","year":"2012","journal-title":"Integr. Zool."},{"key":"ref_89","first-page":"411","article-title":"Factors influencing the re-emergence of plague in Madagascar","volume":"4","author":"Alderson","year":"2020","journal-title":"Emerg. Top. Life Sci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1473-3099(18)30730-8","article-title":"Epidemiological characteristics of an urban plague epidemic in Madagascar, August\u2013November, 2017: An outbreak report","volume":"19","author":"Randremanana","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3201\/eid2502.171974","article-title":"Trends of human plague, Madagascar, 1998\u20132016","volume":"25","author":"Andrianaivoarimanana","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1099\/jmm.0.000915","article-title":"The rise of pneumonic plague in Madagascar: Current plague outbreak breaks usual seasonal mould","volume":"68","author":"Rabaan","year":"2019","journal-title":"J. Med. Microbiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/S1473-3099(20)30487-4","article-title":"The role of louse-transmitted diseases in historical plague pandemics","volume":"21","author":"Barbieri","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_94","unstructured":"WHO (2017). Madagascar Plague Outbreak: External Situation, WHO. Report #14."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e13142","DOI":"10.2196\/13142","article-title":"Google trends predicts present and future plague cases during the plague outbreak in Madagascar: Infodemiological study","volume":"5","author":"Bragazzi","year":"2019","journal-title":"JMIR Public Health Surveill"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0001-706X(97)00096-X","article-title":"Preliminary observations on factors responsible for long persistence and continued outbreaks of plague in Lushoto district, Tanzania","volume":"68","author":"Kilonzo","year":"1997","journal-title":"Acta Trop."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199709043371004","article-title":"Multidrug resistance in Yersinia pestis mediated by a transferable plasmid","volume":"337","author":"Galimand","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1093\/cid\/ciz1230","article-title":"Treatment of human plague: A systematic review of published aggregate data on antimicrobial efficacy, 1939\u20132019","volume":"70","author":"Cooley","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1093\/cid\/ciz1227","article-title":"Antimicrobial treatment patterns and illness outcome among United States patients with plague, 1942\u20132018","volume":"70","author":"Kugeler","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/cid\/ciz1226","article-title":"Antimicrobial treatment of human plague: A systematic review of the literature on individual cases, 1937\u20132019","volume":"70","author":"Nelson","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1586\/14787210.2013.814432","article-title":"Prophylaxis and therapy of plague","volume":"11","author":"Oyston","year":"2013","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Fong, I.W., and Alibek, K. (2009). Plague as a Biological Weapon. Bioterrorism and Infectious Agents: A New Dilemma for the 21st Century, Springer New York.","DOI":"10.1007\/978-1-4419-1266-4"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1128\/AAC.01481-10","article-title":"In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis","volume":"55","author":"Wendte","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3201\/eid2303.161212","article-title":"Successful treatment of human plague with oral ciprofloxacin","volume":"23","author":"Apangu","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Welch, T.J., Fricke, W.F., McDermott, P.F., White, D.G., Rosso, M.L., Rasko, D.A., Mammel, M.K., Eppinger, M., Rosovitz, M.L., and Wagner, D. (2007). Multiple antimicrobial resistance in plague: An emerging public health risk. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0000309"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1128\/AAC.00306-06","article-title":"Resistance of Yersinia pestis to antimicrobial agents","volume":"50","author":"Galimand","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3201\/eid0701.010106","article-title":"Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis","volume":"7","author":"Guiyoule","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fmicb.2013.00044","article-title":"Broad-host-range IncP-1 plasmids and their resistance potential","volume":"4","author":"Popowska","year":"2013","journal-title":"Front. Microbiol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijantimicag.2017.09.015","article-title":"Plasmid-mediated doxycycline resistance in a Yersinia pestis strain isolated from a rat","volume":"51","author":"Cabanel","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Dai, R., He, J., Zha, X., Wang, Y., Zhang, X., Gao, H., Yang, X., Li, J., Xin, Y., and Wang, Y. (2021). A novel mechanism of streptomycin resistance in Yersinia pestis: Mutation in the rpsL gene. PLoS Negl. Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009324"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Taitt, C.R., Leski, T.A., Chen, A., Berk, K.L., Dorsey, R.W., Gregory, M.J., Sozhamannan, S., Frey, K.G., Dutt, D.L., and Vora, G.J. (2020). A survey of antimicrobial resistance determinants in category a select agents, exempt strains, and near-neighbor species. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21051669"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/14760584.7.2.209","article-title":"Current challenges in the development of vaccines for pneumonic plague","volume":"7","author":"Smiley","year":"2008","journal-title":"Expert Rev. Vaccinines"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/S0264-410X(01)00163-3","article-title":"Vaccination against bubonic and pneumonic plague","volume":"19","author":"Titball","year":"2001","journal-title":"Vaccine"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41541-019-0105-9","article-title":"Plague vaccine: Recent progress and prospects","volume":"4","author":"Sun","year":"2019","journal-title":"NPJ Vaccines"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1093\/infdis\/129.Supplement_1.S10","article-title":"K.F. Meyer\u2019s work on plague","volume":"129","author":"Cavanaugh","year":"1974","journal-title":"J. Infect. Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1093\/infdis\/129.Supplement_1.S30","article-title":"Plague immunization. IV. Clinical reactions and serologic response to inoculations of Haffkine and freeze-dried plague vaccine","volume":"129","author":"Meyer","year":"1974","journal-title":"J. Infect. Dis."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/milmed\/138.11.720","article-title":"Clinical and serological responses to plague vaccine U.S.P","volume":"138","author":"Bartelloni","year":"1973","journal-title":"Mil. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1093\/infdis\/129.Supplement_1.S37","article-title":"Plague immunization. V. Indirect evidence for the efficacy of plague vaccine","volume":"129","author":"Cavanaugh","year":"1974","journal-title":"J. Infect. Dis."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1093\/infdis\/129.Supplement_1.S85","article-title":"Live, attenuated Yersinia pestis vaccine: Virulent in nonhuman primates, harmless to guinea pigs","volume":"129","author":"Meyer","year":"1974","journal-title":"J. Infect. Dis."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1517\/14712598.4.6.965","article-title":"Yersinia pestis (plague) vaccines","volume":"4","author":"Titball","year":"2004","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1093\/infdis\/129.Supplement_1.S19","article-title":"Plague immunization. II. Relation of adverse clinical reactions to multiple immunizations with killed vaccine","volume":"129","author":"Marshall","year":"1974","journal-title":"J. Infect. Dis."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0264-410X(95)00090-N","article-title":"A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model","volume":"13","author":"Russell","year":"1995","journal-title":"Vaccine"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1128\/iai.64.6.2180-2187.1996","article-title":"Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge","volume":"64","author":"Andrews","year":"1996","journal-title":"Infect. Immun."},{"key":"ref_124","first-page":"25","article-title":"A filtered non-toxic plague vaccine which protects guinea-pigs and mice","volume":"47","author":"Smith","year":"1966","journal-title":"Br. J. Exp. Pathol."},{"key":"ref_125","unstructured":"Pitt, L.M. (2004, January 13\u201314). Non-human primates as a model for pneumonic plague: Animal models and correlates of protection for plague. Proceedings of the Plague Vaccines Workshop, Gaithersburg, MD, USA."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1016\/j.vaccine.2009.06.078","article-title":"Oral vaccination with LcrV from Yersinia pestis KIM delivered by live attenuated Salmonella enterica serovar Typhimurium elicits a protective immune response against challenge with Yersinia pseudotuberculosis and Yersinia enterocolitica","volume":"27","author":"Branger","year":"2009","journal-title":"Vaccine"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.vaccine.2010.10.033","article-title":"Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge","volume":"29","author":"Branger","year":"2010","journal-title":"Vaccine"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/978-0-387-72124-8_36","article-title":"Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague","volume":"603","author":"Branger","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_129","first-page":"43","article-title":"Current status of the plague in Madagascar and vaccinal prophylaxis with the aid of the EV virus-vaccine","volume":"35","author":"Girard","year":"1942","journal-title":"Bull. Soc. Path. Exot."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.provac.2012.04.003","article-title":"Serologic markers for long-term immunity in humans vaccinated with live Yersinia pestis EV NIIEG","volume":"6","author":"Feodorov","year":"2012","journal-title":"Procedia Vaccinol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/infdis\/129.Supplement_1.S13","article-title":"Plague immunization. I. Past and present trends","volume":"129","author":"Meyer","year":"1974","journal-title":"J. Infect. Dis."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1038\/emi.2014.82","article-title":"Russian vaccines against especially dangerous bacterial pathogens","volume":"3","author":"Feodorova","year":"2014","journal-title":"Emerg. Microbes Infect."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1586\/erv.13.42","article-title":"Live-attenuated Yersinia pestis vaccines","volume":"12","author":"Wang","year":"2013","journal-title":"Expert Rev. Vaccines"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3855\/jidc.2030","article-title":"Developing live vaccines against plague","volume":"5","author":"Sun","year":"2011","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"878","DOI":"10.2174\/1389201014666131226122243","article-title":"Rational considerations about development of live attenuated Yersinia pestis vaccines","volume":"14","author":"Sun","year":"2013","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1128\/CVI.00137-07","article-title":"Yersinia pestis CO92 delta yopH is a potent live, attenuated plague vaccine","volume":"14","author":"Bubeck","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1574-6968.2012.02583.x","article-title":"A Yersinia pestis YscN ATPase mutant functions as a live attenuated vaccine against bubonic plague in mice","volume":"332","author":"Bozue","year":"2012","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Culbreth, M.J., Biryukov, S.S., Shoe, J.L., Dankmeyer, J.L., Hunter, M., Klimko, C.P., Rosario-Acevedo, R., Fetterer, D.P., Moreau, A.M., and Welkos, S.L. (2019). The use of analgesics during vaccination with a live attenuated Yersinia pestis vaccine alters the resulting immune response in mice. Vaccines, 7.","DOI":"10.3390\/vaccines7040205"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Cote, C.K., Biryukov, S.S., Klimko, C.P., Shoe, J.L., Hunter, M., Rosario-Acevedo, R., Fetterer, D.P., Moody, K.L., Meyer, J.R., and Rill, N.O. (2021). Protection elicited by attenuated Live Yersinia pestis vaccine strains against lethal infection with virulent, Y. pestis. Vaccines, 9.","DOI":"10.3390\/vaccines9020161"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.mimet.2009.02.013","article-title":"A strategy to verify the absence of the pgm locus in Yersinia pestis strain candidates for select agent exemption","volume":"77","author":"Jenkins","year":"2009","journal-title":"J. Microbiol. Methods"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/S0264-410X(02)00119-6","article-title":"Determination of the virulence of the pigmentation-deficient and pigmentation-\/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague","volume":"20","author":"Welkos","year":"2002","journal-title":"Vaccine"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cbi.2016.03.030","article-title":"Oral vaccination against plague using Yersinia pseudotuberculosis","volume":"267","author":"Demeure","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"e00296-19","DOI":"10.1128\/IAI.00296-19","article-title":"A recombinant attenuated Yersinia pseudotuberculosis vaccine delivering a Y. pestis YopE(Nt138)-LcrV fusion elicits broad protection against plague and yersiniosis in mice","volume":"87","author":"Singh","year":"2019","journal-title":"Infect. Immun."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"6727","DOI":"10.1016\/j.vaccine.2015.10.074","article-title":"Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plague","volume":"33","author":"Sun","year":"2015","journal-title":"Vaccine"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1128\/IAI.02173-14","article-title":"LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague","volume":"82","author":"Sun","year":"2014","journal-title":"Infect. Immun."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41541-019-0132-6","article-title":"The how\u2019s and what\u2019s of vaccine reactogenicity","volume":"4","author":"Didierlaurent","year":"2019","journal-title":"NPJ Vaccines"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0264-410X(96)00303-9","article-title":"A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague","volume":"15","author":"Williamson","year":"1997","journal-title":"Vaccine"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0264-410X(00)00108-0","article-title":"Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains","volume":"19","author":"Jones","year":"2000","journal-title":"Vaccine"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Al-Jawdah, A.D., Ivanova, I.G., Waller, H., Perkins, N.D., Lakey, J.H., and Peters, D.T. (2019). Induction of the immunoprotective coat of Yersinia pestis at body temperature is mediated by the Caf1R transcription factor. BMC Microbiol., 19.","DOI":"10.1186\/s12866-019-1444-4"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0014-5793(90)80852-A","article-title":"Nucleotide sequence of the Yersinia pestis gene encoding F1 antigen and the primary structure of the protein","volume":"277","author":"Galyov","year":"1990","journal-title":"FEBS Lett."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0014-5793(92)80331-A","article-title":"A new gene of the \u01921 operon of Y. pestis involved in the capsule biogenesis","volume":"297","author":"Karlyshev","year":"1992","journal-title":"FEBS Lett."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/infdis\/109.2.154","article-title":"Role of the capsule of Pasteurella Pestis in bubonic plague in the guinea pig","volume":"109","author":"Donavan","year":"1961","journal-title":"J. Infect. Dis."},{"key":"ref_153","first-page":"391","article-title":"Association-dissociation processes and supermolecular organisation of the capsule antigen (protein F1) of Yersinia pestis","volume":"1","author":"Vorontsov","year":"1990","journal-title":"Biomed. Sci."},{"key":"ref_154","first-page":"278","article-title":"The effects of loss of different virulence determinants on the virulence and immunogenicity of strains of Pasteurella pestis","volume":"39","author":"Burrows","year":"1958","journal-title":"Br. J. Exp. Pathol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/iai.64.11.4580-4585.1996","article-title":"Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis","volume":"64","author":"Anderson","year":"1996","journal-title":"Infect. Immun."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1128\/iai.65.11.4476-4482.1997","article-title":"Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization","volume":"65","author":"Hill","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1128\/iai.63.8.2854-2858.1995","article-title":"Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague","volume":"63","author":"Leary","year":"1995","journal-title":"Infect. Immun."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/mpat.2002.0498","article-title":"Anti-V antigen antibody protects macrophages from Yersinia pestis -induced cell death and promotes phagocytosis","volume":"32","author":"Weeks","year":"2002","journal-title":"Microb. Pathog."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1046\/j.1365-2958.1999.01408.x","article-title":"The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation","volume":"32","author":"Pettersson","year":"1999","journal-title":"Mol. Microbiol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/7391","article-title":"Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury","volume":"5","author":"Sawa","year":"1999","journal-title":"Nat. Med."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.meegid.2009.10.003","article-title":"Amino acid and structural variability of Yersinia pestis LcrV protein","volume":"10","author":"Anisimov","year":"2010","journal-title":"Infect. Genet. Evol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4269\/ajtmh.1990.43.389","article-title":"Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB\/c mice","volume":"43","author":"Simpson","year":"1990","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0264-410X(99)00214-5","article-title":"Expression of a recombinant form of the V antigen of Yersinia pestis, using three different expression systems","volume":"18","author":"Carr","year":"1999","journal-title":"Vaccine"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1016\/j.vaccine.2009.01.050","article-title":"A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague","volume":"27","author":"Chichester","year":"2009","journal-title":"Vaccine"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2249.1999.00859.x","article-title":"An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model","volume":"116","author":"Williamson","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1021\/bp050098r","article-title":"Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague","volume":"21","author":"Powell","year":"2005","journal-title":"Biotechnol. Prog."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pep.2006.12.018","article-title":"Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague","volume":"53","author":"Goodin","year":"2007","journal-title":"Protein Exp. Purif."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"7748","DOI":"10.1016\/j.vaccine.2010.09.062","article-title":"Protection in mice passively immunized with serum from cynomolgus macaques and humans vaccinated with recombinant plague vaccine (rF1V)","volume":"28","author":"Fellows","year":"2010","journal-title":"Vaccine"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1128\/IAI.73.8.5256-5261.2005","article-title":"Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens","volume":"73","author":"Glynn","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0264-410X(00)00159-6","article-title":"A single dose sub-unit vaccine protects against pneumonic plague","volume":"19","author":"Williamson","year":"2000","journal-title":"Vaccine"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1574-695X.1995.tb00196.x","article-title":"A new improved sub-unit vaccine for plague: The basis of protection","volume":"12","author":"Williamson","year":"1995","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/mpat.2000.0385","article-title":"The F1 and V subunit vaccine protects against plague in the absence of IL-4 driven immune responses","volume":"29","author":"Elvin","year":"2000","journal-title":"Microb. Pathog."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/978-94-024-0890-4_12","article-title":"Plague Vaccines: Status and Future","volume":"918","author":"Sun","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4161\/hv.9866","article-title":"Plague vaccines and the molecular basis of immunity against Yersinia pestis","volume":"5","author":"Quenee","year":"2009","journal-title":"Hum. Vaccine"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"6572","DOI":"10.1016\/j.vaccine.2011.06.119","article-title":"Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines","volume":"29","author":"Quenee","year":"2011","journal-title":"Vaccine"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1016\/j.vaccine.2011.04.084","article-title":"Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague","volume":"29","author":"Williamson","year":"2011","journal-title":"Vaccine"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/j.vaccine.2009.02.016","article-title":"CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague","volume":"27","author":"Amemiya","year":"2009","journal-title":"Vaccine"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.vaccine.2021.01.040","article-title":"Single-dose intranasal subunit vaccine rapidly clears secondary sepsis in a high-dose pneumonic plague infection","volume":"39","author":"McCormick","year":"2021","journal-title":"Vaccine"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41541-020-00275-3","article-title":"A new generation needle- and adjuvant-free trivalent plague vaccine utilizing adenovirus-5 nanoparticle platform","volume":"6","author":"Kilgore","year":"2021","journal-title":"NPJ Vaccines"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41541-020-0156-y","article-title":"Flagellin adjuvanted F1\/V subunit plague vaccine induces T cell and functional antibody responses with unique gene signatures","volume":"5","author":"Hamzabegovic","year":"2020","journal-title":"NPJ Vaccines"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/039463200902200115","article-title":"Plant-derived recombinant F1, V, and F1-V fusion antigens of Yersinia pestis activate human cells of the innate and adaptive immune system","volume":"22","author":"Santi","year":"2009","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.vaccine.2005.09.052","article-title":"Intranasal Protollin\/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection","volume":"24","author":"Jones","year":"2006","journal-title":"Vaccine"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pep.2010.10.011","article-title":"Purification and characterization of a recombinant Yersinia pestis V-F1 \u201cReversed\u201d fusion protein for use as a new subunit vaccine against plague","volume":"76","author":"Goodin","year":"2011","journal-title":"Protein Exp. Purif."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1128\/IAI.00581-08","article-title":"A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague","volume":"76","author":"Yamanaka","year":"2008","journal-title":"Infect. Immun."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1016\/S0264-410X(03)00379-7","article-title":"Protective efficacy of a fully recombinant plague vaccine in the guinea pig","volume":"21","author":"Jones","year":"2003","journal-title":"Vaccine"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1128\/IAI.73.6.3598-3608.2005","article-title":"Human immune response to a plague vaccine comprising recombinant F1 and V antigens","volume":"73","author":"Williamson","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1128\/IAI.67.3.1533-1537.1999","article-title":"Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis","volume":"67","author":"Andrews","year":"1999","journal-title":"Infect. Immun."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1128\/IAI.00189-08","article-title":"Vaccination of mice with a Yop translocon complex elicits antibodies that are protective against infection with F1- Yersinia pestis","volume":"76","author":"Ivanov","year":"2008","journal-title":"Infect. Immun."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1128\/iai.62.10.4192-4201.1994","article-title":"Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide","volume":"62","author":"Motin","year":"1994","journal-title":"Infect. Immun."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.vaccine.2009.11.076","article-title":"Amino acid residues 196-226 of LcrV represent a plague protective epitope","volume":"28","author":"Quenee","year":"2010","journal-title":"Vaccine"},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Amemiya, K., Dankmeyer, J.L., Keasey, S.L., Trevino, S.R., Wormald, M.M., Halasohoris, S.A., Ribot, W.J., Fetterer, D.P., Cote, C.K., and Worsham, P.L. (2020). Binding sites of anti-LcrV monoclonal antibodies are more critical than the avidities and affinities for passive protection against Yersinia pestis infection in a bubonic plague model. Antibodies, 9.","DOI":"10.3390\/antib9030037"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1128\/IAI.73.9.6127-6137.2005","article-title":"Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis","volume":"73","author":"Cowan","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1128\/CVI.00333-09","article-title":"Dual-function antibodies to Yersinia pestis LcrV required for pulmonary clearance of plague","volume":"16","author":"Eisele","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1128\/IAI.00856-08","article-title":"Adenovirus-mediated delivery of an anti-V antigen monoclonal antibody protects mice against a lethal Yersinia pestis challenge","volume":"77","author":"Ang","year":"2009","journal-title":"Infect. Immun."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1128\/IAI.05637-11","article-title":"Polymorphisms in the lcrV gene of Yersinia enterocolitica and their effect on plague protective immunity","volume":"80","author":"Miller","year":"2012","journal-title":"Infect. Immun."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1128\/iai.65.2.446-451.1997","article-title":"Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen","volume":"65","author":"Roggenkamp","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.3389\/fimmu.2019.01830","article-title":"Polymorphism in the yersinia LcrV antigen enables immune escape from the protection conferred by an LcrV-secreting Lactococcus lactis in a pseudotuberculosis mouse model","volume":"10","author":"Daniel","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4269\/ajtmh.1997.56.471","article-title":"Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis","volume":"56","author":"Anderson","year":"1997","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1128\/IAI.71.4.2234-2238.2003","article-title":"Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis","volume":"71","author":"Hill","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1128\/IAI.74.5.3068-3070.2006","article-title":"Administration of antibody to the lung protects mice against pneumonic plague","volume":"74","author":"Hill","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Xiao, X., Zhu, Z., Dankmeyer, J.L., Wormald, M.M., Fast, R.L., Worsham, P.L., Cote, C.K., Amemiya, K., and Dimitrov, D.S. (2010). Human anti-plague monoclonal antibodies protect mice from Yersinia pestis in a bubonic plague model. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0013047"},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Liu, W., Ren, J., Zhang, J., Song, X., Lui, S., Chi, X., Chen, Y., Wem, Z., Li, J., and Chen, W. (2017). Identification and characterization of a neutralizing monoclonal antibody that provides complete protection against Yersinia pestis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0177012"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/ITT.S267077","article-title":"Development of anti-Yersinia pestis human antibodies with features required for diagnostic and therapeutic applications","volume":"9","author":"Lillo","year":"2020","journal-title":"Immunotargets Ther."},{"key":"ref_205","first-page":"11","article-title":"Bezlotoxumab: An emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection","volume":"12","author":"Navalkele","year":"2018","journal-title":"Biologics"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1128\/CVI.00116-14","article-title":"Antibodies for treatment of Clostridium difficile infection","volume":"21","author":"Humphreys","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3390\/toxins3081004","article-title":"Monoclonal antibody therapies against anthrax","volume":"3","author":"Chen","year":"2011","journal-title":"Toxins"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cmi.2018.04.024","article-title":"Monoclonal antibodies as anti-infective products: A promising future?","volume":"25","author":"Pelfrene","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2217\/fmb.12.116","article-title":"Mechanisms of antibiotic resistance in Burkholderia pseudomallei: Implications for treatment of melioidosis","volume":"7","author":"Schweizer","year":"2012","journal-title":"Future Microbiol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1021\/jm5016846","article-title":"Clostridium difficile drug pipeline: Challenges in discovery and development of new agents","volume":"58","author":"Jarrad","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_211","unstructured":"Paz, J.C., and West, M.P. (2014). Chapter 13\u2014Infectious diseases. Acute Care Handbook for Physical Therapists, W.B. Saunders. [4th ed.]."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"2475067","DOI":"10.1155\/2016\/2475067","article-title":"Mechanisms of antimicrobial resistance in ESKAPE pathogens","volume":"2016","author":"Santajit","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.gendis.2019.04.001","article-title":"Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review","volume":"6","author":"Pachori","year":"2019","journal-title":"Genes Dis."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/07388551.2015.1114465","article-title":"Anti-Ebola therapies based on monoclonal antibodies: Current state and challenges ahead","volume":"37","author":"Alvarez","year":"2017","journal-title":"Crit. Rev. Biotechnol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"e00405-19","DOI":"10.1128\/JVI.00405-19","article-title":"Human monoclonal antibodies potently neutralize Zika virus and select for escape mutations on the lateral ridge of the envelope protein","volume":"93","author":"Bailey","year":"2019","journal-title":"J. Virol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/jama.2020.10245","article-title":"Monoclonal antibodies for prevention and treatment of COVID-19","volume":"324","author":"Marovich","year":"2020","journal-title":"JAMA"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"110337","DOI":"10.1016\/j.biopha.2020.110337","article-title":"Monoclonal antibody as a potential anti-COVID-19","volume":"129","author":"Jahanshahlu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1742-4690-11-24","article-title":"Structural basis for the inhibition of HIV-1 Nef by a high-affinity binding single-domain antibody","volume":"11","author":"Matz","year":"2014","journal-title":"Retrovirology"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.addr.2020.12.004","article-title":"Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy","volume":"169","author":"Tiruthani","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"101427","DOI":"10.1016\/j.smim.2020.101427","article-title":"Quantum leap of monoclonal antibody (mAb) discovery and development in the COVID-19 era","volume":"50","author":"Pecetta","year":"2020","journal-title":"Semin. Immunol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/10\/1421\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:10:54Z","timestamp":1760166654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/10\/1421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,9]]},"references-count":220,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["biomedicines9101421"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9101421","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,9]]}}}